Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Qianjiang Yongan Pharmaceutical Co Ltd
Other
Qianjiang Yongan Pharmaceutical Co Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
|
Other
-¥43.3m
|
CAGR 3-Years
-238%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Other
¥0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Other
-¥1.3B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Other
-¥65.8m
|
CAGR 3-Years
57%
|
CAGR 5-Years
43%
|
CAGR 10-Years
-12%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Other
-¥574m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-55%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Other
-¥72.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Qianjiang Yongan Pharmaceutical Co Ltd
Glance View
Qianjiang Yongan Pharmaceutical Co., Ltd. engages in the research, development, production and sales of taurine products. The company is headquartered in Qianjiang, Hubei and currently employs 927 full-time employees. The company went IPO on 2010-03-05. The firm operates through three main segments. The Taurine Products segment is mainly engaged in the research, development, manufacture and sales of taurine products, as well as the manufacture and sales of ethylene oxide. The Food Supplement segment is mainly involved in the research, development, manufacture and sales of dietary supplement, as well as the import and sales of overseas dietary supplement. The Health Field segment is mainly involved in the equity or industrial investment in health-related field.
See Also
What is Qianjiang Yongan Pharmaceutical Co Ltd's Other?
Other
-43.3m
CNY
Based on the financial report for Dec 31, 2025, Qianjiang Yongan Pharmaceutical Co Ltd's Other amounts to -43.3m CNY.
What is Qianjiang Yongan Pharmaceutical Co Ltd's Other growth rate?
Other CAGR 3Y
-238%
Over the last year, the Other growth was -17%. The average annual Other growth rates for Qianjiang Yongan Pharmaceutical Co Ltd have been -238% over the past three years .
